| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36 |
| filingDate |
1977-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1978-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b211cd65aa41f68b6124b0072b4143 |
| publicationDate |
1978-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4079135-A |
| titleOfInvention |
Morpholine derivatives as antidepressants |
| abstract |
The disclosure relates to new morpholine derivatives which possess antidepressant activity, to processes for the manufacture of said derivatives and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(4H-2,3-dihydro-1,4-benzoxazin-3-one-4-ylmethyl)morpholine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004192766-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004192765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008004338-A1 |
| priorityDate |
1973-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |